213 related articles for article (PubMed ID: 34229044)
1. Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis.
Takeuchi T; Yoshida H; Tanaka S
Autoimmun Rev; 2021 Sep; 20(9):102884. PubMed ID: 34229044
[TBL] [Abstract][Full Text] [Related]
2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
3. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis.
Li X; Yuan FL; Lu WG; Zhao YQ; Li CW; Li JP; Xu RS
Biochem Biophys Res Commun; 2010 Jun; 397(2):131-5. PubMed ID: 20513356
[TBL] [Abstract][Full Text] [Related]
4. Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis.
Yokota K; Sato K; Miyazaki T; Aizaki Y; Tanaka S; Sekikawa M; Kozu N; Kadono Y; Oda H; Mimura T
Arthritis Rheumatol; 2021 Jul; 73(7):1145-1154. PubMed ID: 33512089
[TBL] [Abstract][Full Text] [Related]
5. [Rheumatoid arthritis and cytokines].
Kaneko S; Kondo Y; Yokosawa M; Sumida T
Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
[TBL] [Abstract][Full Text] [Related]
6. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
7. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
Kaur S; White S; Bartold M
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanisms of bone destruction in rheumatoid arthritis].
Nanki T
Clin Calcium; 2007 Apr; 17(4):510-6. PubMed ID: 17404479
[TBL] [Abstract][Full Text] [Related]
9. Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention.
Karmakar S; Kay J; Gravallese EM
Rheum Dis Clin North Am; 2010 May; 36(2):385-404. PubMed ID: 20510240
[TBL] [Abstract][Full Text] [Related]
10. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
[TBL] [Abstract][Full Text] [Related]
11. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson SB; Amin A
Rheumatology (Oxford); 2002 Sep; 41(9):972-80. PubMed ID: 12209029
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-mediated bone destruction in rheumatoid arthritis.
Jung SM; Kim KW; Yang CW; Park SH; Ju JH
J Immunol Res; 2014; 2014():263625. PubMed ID: 25295284
[TBL] [Abstract][Full Text] [Related]
13. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
14. Combination of gp130-targeting and TNF-targeting small molecules in alleviating arthritis through the down-regulation of Th17 differentiation and osteoclastogenesis.
Park YH; Kim HJ; Lee K; Choi Y; Heo TH
Biochem Biophys Res Commun; 2020 Feb; 522(4):1030-1036. PubMed ID: 31818460
[TBL] [Abstract][Full Text] [Related]
15. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms of bone damage and repair in the arthritic joint.
Duncan H
J Rheumatol Suppl; 1983 Dec; 11():29-37. PubMed ID: 6583413
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Kotake S; Sato K; Kim KJ; Takahashi N; Udagawa N; Nakamura I; Yamaguchi A; Kishimoto T; Suda T; Kashiwazaki S
J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Anti-bone resorbing treatment for rheumatoid arthritis.].
Tanaka Y
Clin Calcium; 2018; 28(5):630-636. PubMed ID: 29731457
[TBL] [Abstract][Full Text] [Related]
19. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Fibrinolytic Factors in Bone Destruction Caused by Inflammation.
Kanno Y
Cells; 2024 Mar; 13(6):. PubMed ID: 38534360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
